top of page
background web 2.png

Sponsors

GOLD SPONSORS

genpharm new logo.png

At Genpharm, our mantra is clear – Bringing Cures To MENAT Patients. Genpharm is a pharmaceutical market access company focused on niche therapeutics and diagnostics for rare diseases and specialty. We provide fast and sustainable market access solutions into the MENAT (Middle East, North Africa, and Turkey) region to our strategic partners. We act as the exclusive regional commercial partner for pharmaceutical pioneers in the MENAT. Our expertise is maintained through our cross-functional departments such as Medical Affairs, PV, Regulatory, Quality, Logistics, and more. We provide strategic advice and solutions on Business Development opportunities as well as pathway for companies evaluating their entry into MENAT. We are proud to be the first company to successfully introduce gene therapy in the MENAT region. www.genpharmservices.com

CMRC-Logo---UAE.png

CMRC is a specialized Rehabilitation Hospital and Long-term care provider in the MENA Region. At Cambridge Medical and Rehabilitation Center, we provide specialized rehabilitation hospital setup and dedicated medical care and rehabilitation services to patients requiring short-term comprehensive rehabilitation and long-term care for patients with chronic illness or injury. We deliver a superior level of service tailored to meet the individual treatment needs of every patient in our care and encourage family members’ involvement in the patient’s treatment plan.

SILVER SPONSOR

PTC-Logo-NEW-2025.png

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. Our mission is to provide access to best-in-class treatments for patients with little to no treatment options. For 25 years, we have been successful delivering on our mission by pursuing groundbreaking science and technology to bring multiple innovative therapies that are transforming patient’s lives, globally. Everything we've done, every study, every experiment, every investment is made first and foremost to change the course of rare diseases and the lives of our patients.

BRONZE SPONSOR

METROMED.png

Established in 1990, MetroMed is a pioneer among UAE healthcare distributors, known for its professional excellence and reputation as one of the region’s medicale marketing partners of choice. Headquartered in Dubai, MetroMed is a company of Mazrui International LLC, a privately-held diversified conglomerate with operations across numerous industries and asset classes in the MENA region. The Mazrui International group of companies are market leaders in several sectors including Oil & Gas, Construction & Building Materials, Retail, Industrial, and Healthcare. Each Mazrui International company benefits from a world-class support structure delivered through a Shared Services model. Know more about Mazrui International. MetroMed supplies pharmaceutical products, medical devices and equipment, consumer healthcare, and veterinary products to pharmacies, government and private hospitals, supermarkets, and veterinary clinics throughout the United Arab Emirates. Know more about veterinary products. Backed by decades of regional experience, our company has been consistent in creating a valuable market presence for our partner brands and delivering above-average market share growth. As a result, we foster long term partnerships and associations and are regarded as a specialty distributor of choice boasting a valuable product portfolio and an ever-expanding list of new partners.

EXHIBITORS

avernus.png

At Avernus Pharma, we are working together to help patients around the world by changing the way disease is treated. The journey towards solving the big problems that will help people live fuller lives through a personalized treatment approaches. We recognize the unique responsibility we hold to not only provide top-quality care to our customers, but to serve as role models for corporate responsibility and societal advancement for these areas. Positively impacting the lives of our patients and communities along with customer satisfaction at large is not only our promise, but our privilege. Avernus Pharma has managed to support our global partners to expand their business across the GCC with the expertise of talented and specialized teams as well as by avoiding supply chain disruptions and distribution obstacles, ensuring ongoing development of novel treatments for patients. We are condent that, together with our Global partners, we have the right people to achieve our milestones, and more importantly, the milestones of our customers.

PHARMALINK new.png

Pharmalink is a leading UAE-based healthcare organization with over 30 years of experience, dedicated to enhancing patient access to high-quality medical solutions across the GCC region. Their comprehensive portfolio includes pharmaceuticals, biosimilars, and branded generics, addressing diverse therapeutic areas such as rare disease , Neurology , gastroenterology, oncology, and cardiovascular health. By partnering with global healthcare innovators, Pharmalink continues to fulfill its mission of improving community health outcomes.

LOGO-DELTA-MEDICAL-LLC-2025-new.png

“Combining local market expertise and the latest technological advancements, Delta Medical LLC has been meeting the UAE’s ever-changing market needs for over 30 years.” Founded in 1985 in Abu Dhabi, Delta Medical LLC is one of the UAE’s leading distribution agents for multinational products in the medical, wellness, health, and beauty sectors. Catering to over 3000 outlets in the UAE; including pharmacies, hospitals, clinics, wholesalers, supermarkets and various other retail outlets; Delta Medical LLC is known for high-quality products and excellent service. Combining local market expertise and the latest technological advancements, Delta Medical LLC has successfully been meeting the UAE’s ever-changing market needs for over 30 years. With a business model rooted in innovation and open communication, and acomprehensive understanding of the UAE’s consumer needs, the team at Delta Medical LLC works endlessly to implement their knowledge to continuously enhance their services and product offerings. Through a holistic approach to distribution and logistical needs, Delta Medical LLC provides a complete range of solutions with an array of complimentary services including sales, marketing, and healthcare management, designed to facilitate the acceleration of growth through tactical and strategic partnerships. Delta Medical LLC, along with its sister companies, provides direct account coverage in all healthcare and consumer channels in the UAE, employing over 200 talented individuals.

logo-versalya-ITALFARMACO-VV.png

Versalya Pharma is a European pharmaceutical company established in 2012 and headquartered in Alcobendas, Madrid, Spain. It operates as an affiliate of the Italfarmaco Group, a prominent Italian pharmaceutical conglomerate. Versalya Pharma was founded to facilitate the expansion of the Italfarmaco Group's business into Africa and the Middle East, focusing on the promotion and sales of ethical and over the counter (OTC) products for women and children. Parent Company: Italfarmaco Group: Founded in 1938, Italfarmaco is a privately owned European pharmaceutical company engaged in researching, developing, manufacturing, and promoting prescription and OTC drugs in various fields, including oncology, palliative care, cardiology, neurology, and women's health. Expansion into Rare Diseases – Duchenne Muscular Dystrophy (DMD): In line with its commitment to addressing unmet medical needs, Italfarmaco has recently expanded into the rare disease space with a focus on Duchenne muscular dystrophy (DMD). This strategic entry marks a significant milestone for the company as it aims to contribute to the management of this severe neuromuscular disorder.

Taiba-Logo.png

taiba is a leading specialty marketing, sales and distribution company in the MENA region, providing innovative treatments to patients suffering from orphan and rare diseases. taiba vision is to cover the unmet medical need in its region providing high quality products and high level of service to healthcare organizations and hospitals and commitment to patient treatment. taiba focus is addressing the needs of rare disease patients and providing them access to innovative medicines either through name patients sales or through commercialization. Over the last fifteen years taiba has earned a reputation as a regional leading company in rare diseases and currently represents leading multinational companies pioneer in their fields such as Alnylam, Aegerion, Biomarin, Genzyme, Lucane, Veloxis, Vertex etc.

Nutricia-logo-strapline-rgb-solid.png

We have been pioneering nutritional solutions since 1896, when our founders first began their early support of mothers and their infants. Since then, our nutritional solutions have transformed the lives of millions of people around the world. That pioneering spirit lives on today with an ongoing commitment to provide life-transforming nutrition at key moments throughout life.

Xtremity.png

Realize a better Prosthetic & Orthotic Experience Xtremity Prosthetics and Orthotics is a specialized health clinic where treatment is provided by a specialized team which comprises allied health professionals as well as medical professionals giving a multidisciplinary approach towards prosthetic and orthotic rehabilitation care. During the current evolution of digital era, we thrive to maintain and embrace the digital transformation in our specialized care. Our service includes the utilization of the latest cutting-edge technology i.e., 3D printing, and CAD-based production, which helps us to serve the children and adult population, with functionally enhanced Orthoses and Prostheses. This in turn not only raises the quality of the product but also enhances the overall standard of the Prosthetic and Orthotic market in the country.

Agilus-Diagnostics-Logo.png

Founded in 1995, Agilus Diagnostics Ltd. is India’s largest diagnostics service provider, with an extensive network of over 410 laboratories, 4,000 customer touchpoints, and 12,000 direct clients and pickup points. Spanning 1,000+ cities across 25 states and five union territories, Agilus has solidified its position as a leader in diagnostics. Dr. Anand K serves as the Managing Director and Chief Executive Officer, steering the company towards innovation and excellence. Agilus operates a state-of-the-art Global Reference Laboratory in Mumbai, complemented by five regional reference laboratories located in Gurugram (Haryana), Bengaluru (Karnataka), Chennai (Tamil Nadu), Kolkata (West Bengal), and Cochin (Kerala). The company’s laboratories are renowned for quality, with 43 NABL-accredited facilities and two CAP-accredited laboratories in Mumbai and Dubai. Its international footprint extends across the SAARC region, Sub-Saharan Africa, the Commonwealth of Independent States, and the Middle East. In May 2023, the company embarked on a transformative journey, unveiling its new identity as Agilus Diagnostics. The name "Agilus" is derived from the Latin term agilis, meaning agility, and reflects the fusion of “agile” and “us,” symbolizing the company’s focus on adaptability and innovation. Agilus Diagnostics offers an expansive portfolio of over 3,600 diagnostic tests, ranging from routine to specialized diagnostics, catering to various specialties. Over the past two years, the company has introduced more than 200 innovative tests, including cutting-edge offerings in genomics, molecular pathology, cancer diagnostics, reproductive medicine, rare diseases, and inherited disorders. Agilus Diagnostics also offers comprehensive corporate wellness programs and preventive health packages. The company’s commitment to advancing healthcare is underpinned by a robust team of over 4,000 medical and scientific professionals, including 400+ doctors, pathologists, radiologists, and scientists. By leveraging integrated technology platforms and data-driven insights, Agilus delivers a seamless, customer-centric experience. This includes secure QR-coded reports, convenient booking options via call centers, mobile apps, and websites, and fast, reliable home collection services. Agilus Diagnostics conducts over 40 million tests annually, serving more than 20 million customers. The company’s relentless pursuit of excellence has been recognized with numerous accolades, including the National Diagnostic Chain of the Year Award at the Economic Times Healthcare Awards 2024 and the Best Diagnostic Chain of the Year Award at the ASSOCHAM Healthcare Awards 2024.Guided by a passion for innovation and a commitment to quality, Agilus Diagnostics is at the forefront of next-generation diagnostics and genomics, striving to create healthier communities through agility, expertise, and care.

Swixx-logo-(1).png

Swixx BioPharma: Modern Medicines for All Swixx BioPharma was founded in December 2014 by a group of experienced pharma professionals with the vision of becoming the partner of choice for biopharma companies opting for an indirect route to market, by providing best-in-class pharma services, building on deep industry knowledge, and ultimately improving patient outcomes. Swixx’s mission is to work closely with the partners and the broader healthcare communities to unlock access to innovative treatments across four strategic therapeutic areas: Rare Diseases, Oncology/Hematology, Specialty Care, and Vaccines. Over the last ten years, Swixx has swiftly evolved into one of the largest, most professional, and most reliable partners for international healthcare companies across Central & Eastern Europe, Russia/Eurasia, and Greece. In a major step forward, Swixx expanded to the Middle East & Africa in September 2023, establishing a regional headquarters in Dubai, and bringing its proven model to new high-potential markets. In May 2024, Swixx further extended its global footprint into Latin America through a strategic acquisition and combination with Laboratorios Biopas S.A. Demonstrating its leadership and excellence, Swixx was honored at the PMEA Awards for its Rare Disease Academy project, for Excellence in Engagement through Digital Channels and New Technology and earning a High Commendation for Excellence in Rare Diseases or Orphan Disorders. With over 1,900 employees and sales exceeding €1.0 bn in 2024, Swixx was recognized by The Financial Times in the FT1000 List as one of the fastest-growing companies in Europe.

advance-care-logo.png

Advance Care is one of the leading Orthotics Prosthetics and Rehabilitation service providers based in UAE.They strive to take traditional handcrafting workflows to the next level by combining new multidisciplinary ideas to improve operational readiness and cost effectiveness. To meet the demands of each patient we give a high-quality product as well as excellent service to help our patients reclaim their lives. We are enthusiastic about the potential of creative and evidence-based solutions to enhance people’s lives. We are a patient-oriented organization, believes in patient satisfaction and quality services. Advance care is providing a wide range of custom made and over the shelf Orthotics Prosthetics devices, mobility aids and other healthcare related solutions and services. Our organization has strong collaboration with leading International brands to provide an effective and efficient bracing solution to local community.

Pharmapal-logo.png

Pharmapal House of wellbeing was founded in 1998 as a leading Pharmaceutical, Nutraceutical and Dental product distribution company based in the UAE. With speciality in introducing and distributing innovative healthcare products that deliver high value and help develop the evolving practice of medicine and wellbeing in the middle east. Pharmapal takes pride in its deeply rooted values to provide innovation and excellence in the service of better health to all .With a strong distribution network that covers KSA, Kuwait, Qatar, Bahrain, Jordan and Lebanon as well as the UAE and a highly specialized team of wellbeing specialists.

SCIENTIFIC PARTNER

LOGO - Gulf Academy For Medical Training LLC.png

MANAGED BY:

NEW PEMS LOGO web.png

For more information, please contact:

Ibrahim Villaruel - Event Coordinator   |   +971 58 553 2887   |   e.villaruel@pems.me

© 2024  by 4th International Peadiatric Neurodisability & Neurorehabilitation Conference. All Rights Reserved.

bottom of page